These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27692139)

  • 1. Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD.
    Tøttenborg SS; Lange P; Johnsen SP; Nielsen H; Ingebrigtsen TS; Thomsen RW
    Respir Med; 2016 Oct; 119():160-167. PubMed ID: 27692139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
    Mueller S; Wilke T; Bechtel B; Punekar YS; Mitzner K; Virchow JC
    Respir Med; 2017 Jan; 122():1-11. PubMed ID: 27993284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Adherence to Maintenance Medication in Patients with COPD and Acute Exacerbation Occurrence and Cost in China: A Retrospective Cohort Database Study.
    Chen R; Gao Y; Wang H; Shang H; Xuan J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():963-971. PubMed ID: 32440108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of therapy among COPD patients who experience an improvement in exacerbation status.
    Reilev M; Kristensen KB; Søndergaard J; Henriksen DP; Thompson W; Pottegård A
    Eur J Clin Pharmacol; 2019 Jul; 75(7):1025-1032. PubMed ID: 30903196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
    Punekar YS; Landis SH; Wurst K; Le H
    Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach.
    Belleudi V; Di Martino M; Cascini S; Kirchmayer U; Pistelli R; Formoso G; Fusco D; Davoli M; Agabiti N;
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1295-1304. PubMed ID: 27396695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
    Dong YH; Chang CH; Gagne JJ; Hsu CL; Lai MS
    Pharmacotherapy; 2016 Jan; 36(1):26-37. PubMed ID: 26799347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.
    Lin HW; Chung CL; Lin YS; Yu CM; Lee CN; Bien MY
    PLoS One; 2015; 10(7):e0130102. PubMed ID: 26158649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
    JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity in COPD patients decreases short-acting bronchodilator use and the number of exacerbations.
    Katajisto M; Koskela J; Lindqvist A; Kilpeläinen M; Laitinen T
    Respir Med; 2015 Oct; 109(10):1320-5. PubMed ID: 26298024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing socioeconomic inequalities in COPD care in the hospital outpatient setting - A nationwide initiative.
    Tøttenborg SS; Lange P; Thomsen RW; Nielsen H; Johnsen SP
    Respir Med; 2017 Apr; 125():19-23. PubMed ID: 28340857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.